Cardiac characteristics of Fabry disease from baseline enrolment data in a nationwide prospective Japanese registry

  • Toru Kubo
  • , Yuichiro Maekawa
  • , Kenichi Hongo
  • , Saori Yamamoto
  • , Yasuhiro Izumiya
  • , Hiroyuki Yamakawa
  • , Toshiyuki Yano
  • , Koji Higuchi
  • , Yuki Kuramoto
  • , Naoki Nakagawa
  • , Masashi Amano
  • , Yu Yamada
  • , Masayoshi Oikawa
  • , Yuichiro Iida
  • , Kenichi Tsujita
  • , Yuya Matsue
  • , Hideo Izawa
  • , Atsushi Suzuki
  • , Yuji Nagatomo
  • , Toshiyuki Nagai
  • Keisuke Kida, Kazuto Nakamura, Kazufumi Nakamura, Hiroki Ikenaga, Takahiro Kanda, Yoshiharu Kinugasa, Hiromasa Ito, Kenji Onoue, Hiromitsu Kanamori, Hiroaki Kitaoka

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Fabry disease (FD) is an important disease in the cardiovascular field because a significant proportion of patients with FD die from cardiac lesions. Methods: A multicenter prospective registration study of patients with FD throughout Japan was designed. The baseline clinical characteristics of 175 patients are presented here. Results: The mean ages at enrolment and at diagnosis were 52 ± 16 and 43 ± 18 years, respectively, with men accounting for 38 % of the patients. In the cohort, 24 % of the patients had the classical hemizygote male type, whereas 14 % had the late-onset male type, and 62 % had the heterozygote female type. On electrocardiography data at enrolment in 92 patients with left ventricular hypertrophy (LVH) (maximum LV wall thickness > 12 mm), 12 % showed a short PQ interval (< 120 msec), and 33 % had a short PendQ interval (≤ 40 msec). The Sokolow-Lyon voltage was high (6.1 ± 13.1 mv). Regarding the distribution of LVH patterns, 77 % of the patients showed concentric diffuse LVH, 16 % of the patients had asymmetric septal hypertrophy, and 1 % of the patients had hypertrophy confined to the LV apex. With regard to implantation of cardiac devices, permanent pacemakers had been implanted in 5 % of the patients and defibrillators had been implanted in 12 patients (7 %), for primary prevention in nine patients and for secondary prevention in three patients. Conclusion: As the first large-scale prospective registry of FD patients in Japan, this study has provided valuable baseline data for the cardiac features and management of FD.

Original languageEnglish
Article number134071
JournalInternational Journal of Cardiology
Volume445
DOIs
Publication statusPublished - 15-02-2026
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Cardiac characteristics of Fabry disease from baseline enrolment data in a nationwide prospective Japanese registry'. Together they form a unique fingerprint.

Cite this